P110

InvestigationalMitochondrial Dynamics ResearchBrain, mood & sleepLongevity & cellular

Awaiting review, BioHarmony verdict

Not yet scored. Queued for review; until then rely on the status and sources below.

What is P110?

P110 is a preclinical peptide inhibitor of the stress-associated Drp1-Fis1 interaction. Recent animal and cell studies do not establish human safety or effectiveness.

Saved on this device only.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

No approved-label or study protocol is recorded for P110 yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalInvestigational
CompoundingEligibility not established.

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.